{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/hypothyroidism/","result":{"data":{"firstChapter":{"id":"cf0a606b-f582-5671-a84d-a1a3a12b7180","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field bad8c210-0333-4df5-a82e-3568df0b86a7 --><h1>Hypothyroidism: Summary</h1><!-- end field bad8c210-0333-4df5-a82e-3568df0b86a7 -->","htmlStringContent":"<!-- begin item 7d66bcf2-dd81-489b-8409-f6e7c5c9b898 --><!-- begin field 06ca5aab-4d02-4349-8cce-bfe3490b3494 --><ul><li>Hypothyroidism is a common condition of thyroid hormone (thyroxine [T4] and tri-iodothyronine [T3]) deficiency.<ul><li>Overt hypothyroidism is a condition where thyroid-stimulating hormone (TSH) levels are above the normal reference range (usually above 10 mU/L) and free thyroxine (FT4) is below the normal reference range.</li><li>Subclinical hypothyroidism is a condition where TSH levels are above the normal reference range, but T3 and T4 levels are within the normal reference range.</li><li>Secondary hypothyroidism is a condition where TSH levels are inappropriately low or normal (or rarely raised), but FT4 is below the normal reference range.</li></ul></li><li>Primary hypothyroidism may be caused by iodine deficiency, autoimmune thyroiditis, post-ablative therapy or surgery, drugs (such as amiodarone and lithium), transient thyroiditis, and thyroid infiltrative disorders.</li><li>Secondary hypothyroidism is caused by a pituitary or hypothalamic disorder.</li><li>Complications of hypothyroidism include dyslipidaemia, metabolic syndrome, coronary heart disease and stroke, heart failure, neurological and cognitive impairments, and adverse maternal and fetal outcomes in pregnancy.</li><li>The symptoms and signs of hypothyroidism may be mild and non-specific, especially in the elderly, including fatigue, cold intolerance, weight gain, constipation, and depression.</li><li>Assessment of a person with suspected hypothyroidism should include:<ul><li>Asking about symptoms, non-thyroidal illness, drug treatments, and risk factors for hypothyroidism such as family history or associated autoimmune disease.</li><li>Examining for signs and complications of hypothyroidism; thyroid enlargement or nodules; signs of other autoimmune disease.</li><li>Checking the serum TSH level, and if raised, measuring the FT4 level in the same sample.</li><li>Considering arranging repeat TFTs if clinically indicated.</li><li>Arranging additional blood tests including thyroid peroxidase antibodies, if indicated.</li></ul></li><li>Management of a person with overt hypothyroidism involves:<ul><li>Arranging emergency admission if a serious complication such as myxoedema coma is suspected.</li><li>Arranging urgent referral to an endocrinologist if secondary hypothyroidism is suspected.</li><li>Arranging referral or discussing with an endocrinologist if specialist management is needed.</li><li>Offering advice on sources of information and support.</li><li>Starting treatment with levothyroxine (LT4) monotherapy, reviewing symptoms and TFTs every 3 months, and making LT4 dose adjustments if needed.</li><li>Not initiating liothyronine (LT3) alone, combination therapy (LT4 and LT3), or natural thyroid extracts in primary care.</li><li>Checking TSH annually once the TSH is stable.</li><li>Checking for underlying causes if TFTs remain abnormal or there are persistent symptoms despite adequate or escalating LT4 doses, and considering referral to endocrinology if no cause is found.</li></ul></li><li>Management of a person with subclinical hypothyroidism involves:<ul><li>Starting treatment with LT4 monotherapy depending on the TSH level, the person's age, and presence of symptoms.</li><li>Reviewing symptoms and TFTs every 3 months and making LT4 dose adjustments if needed.</li><li>Measuring TSH and FT4 appropriately if the person is untreated or has stopped LT4.</li></ul></li><li>Referral to an endocrinology specialist should be arranged for a woman with overt or subclinical hypothyroidism who is:<ul><li>Planning a pregnancy.</li><li>Pregnant (urgent TFTs are needed and the LT4 dose should be adjusted on specialist advice).</li><li>Postpartum and was treated with LT4 in pregnancy.</li><li>Diagnosed with postpartum thyroiditis.</li></ul></li></ul><!-- end field 06ca5aab-4d02-4349-8cce-bfe3490b3494 --><!-- end item 7d66bcf2-dd81-489b-8409-f6e7c5c9b898 -->","topic":{"id":"f1d76bc1-c8dd-515b-a709-48c70c829658","topicId":"ebfc5032-6653-4b11-895c-5080f933e861","topicName":"Hypothyroidism","slug":"hypothyroidism","aliases":[],"chapters":[{"id":"cf0a606b-f582-5671-a84d-a1a3a12b7180","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"795eb9d9-4e15-51f6-81f4-7cc1b69ca74e","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"a8d7a846-dfa6-5db5-ba95-fb161fd48c6e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"d8567cc1-0642-5e9e-ad6c-8ca4abf5fa6e","slug":"changes","fullItemName":"Changes"},{"id":"c5e99cd1-e0c7-5efd-84bb-15bac6122b1d","slug":"update","fullItemName":"Update"}]},{"id":"2b8464ae-3182-517a-85be-6acc656616c5","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"17d5ebf3-bdca-50d2-a4f5-245d191f4973","slug":"goals","fullItemName":"Goals"},{"id":"9162c6a3-edc4-5319-9418-04b2cb656ce6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2ae5c1d9-638e-52fa-b738-9561cd11b0ab","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7fec82ae-e144-56a7-b1e8-8744c35e227e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"610f052f-83a2-5b06-b5e6-4aa272ef73a6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a578bde3-0d84-54f7-814d-18ed38e6038a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"66bb9b4f-4de2-5da7-aba1-ec9bff4b2454","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"4b8f382f-673d-5804-8291-438e21e32790","slug":"definition","fullItemName":"Definition"},{"id":"ef0d96cd-207c-5814-93cf-c96870e2251d","slug":"causes","fullItemName":"Causes"},{"id":"09adb285-1d01-592a-9443-295b45c7d78b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9bfb88d8-8d33-53a3-8d0e-1b202457fb2e","slug":"complications","fullItemName":"Complications"},{"id":"5ff1ef9f-bb77-5feb-bd5a-12d7b43cca9d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"cfe582c4-479a-5d44-b893-ac46a1a80b29","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"6884c3db-6165-566b-a4ca-3e933de77714","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"42799fb8-7252-541e-9af1-27ebc28710b7","slug":"assessment","fullItemName":"Assessment"},{"id":"e850b740-b6cf-55a7-aed8-7372b7f13b05","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"d817ab4c-e7a3-582a-94fa-fcffd9c2d4f6","slug":"screening","fullItemName":"Screening"}]},{"id":"b377a2c4-68d7-573f-912f-123b99d0aba1","slug":"management","fullItemName":"Management","subChapters":[{"id":"daacd844-c78f-5626-a2ea-93077f98f729","slug":"overt-hypothyroidism-non-pregnant","fullItemName":"Scenario: Overt hypothyroidism (non-pregnant)"},{"id":"e358d249-a2f3-5a06-b301-2119af9ae164","slug":"subclinical-hypothyroidism-non-pregnant","fullItemName":"Scenario: Subclinical hypothyroidism (non-pregnant)"},{"id":"9e4d552e-5fb3-571b-b14a-fec340b943f0","slug":"preconception-or-pregnant","fullItemName":"Scenario: Preconception or pregnant"},{"id":"611f3939-9d39-5545-b225-f9b33fdb095e","slug":"postpartum","fullItemName":"Scenario: Postpartum"}]},{"id":"7b2d6d51-4029-5c06-8789-30e0056076fa","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"ee5ac1fb-6ba7-5e52-9861-d62637c03bf0","slug":"levothyroxine","fullItemName":"Levothyroxine"}]},{"id":"2aaf1754-ba79-5b47-b2a5-74fe8f6af4da","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"7669c894-3a85-55c7-b689-cb4b710a838a","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"840d7de5-8c31-5696-9de6-c80ce1bbfec7","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"299c20bf-2a22-5681-99ad-5f02f1395969","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"dd3df39b-4a5c-5416-af8d-dcdbf46bd255","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a88d4431-778a-5793-9557-9f806339a95b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1987302d-f600-55e0-a528-d3486c49048e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a49e5d2f-75e4-5219-a4d6-fd4a5595a776","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"f1d76bc1-c8dd-515b-a709-48c70c829658","topicId":"ebfc5032-6653-4b11-895c-5080f933e861","topicName":"Hypothyroidism","slug":"hypothyroidism","aliases":[],"topicSummary":"Hypothyroidism is the clinical result of impaired production of thyroid hormones (thyroxine [T4] and tri-iodothyronine [T3]).","lastRevised":"Last revised in August 2020","nextPlannedReviewBy":"2025-01-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2025-01","nextPlannedReviewByDisplay":"January 2025","specialities":[{"id":"aa304738-44fc-5b1d-af3b-42cce5d27663","name":"Endocrine and metabolic","slug":"endocrine-metabolic"}],"chapters":[{"id":"cf0a606b-f582-5671-a84d-a1a3a12b7180","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"795eb9d9-4e15-51f6-81f4-7cc1b69ca74e","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"a8d7a846-dfa6-5db5-ba95-fb161fd48c6e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"d8567cc1-0642-5e9e-ad6c-8ca4abf5fa6e","slug":"changes","fullItemName":"Changes"},{"id":"c5e99cd1-e0c7-5efd-84bb-15bac6122b1d","slug":"update","fullItemName":"Update"}]},{"id":"2b8464ae-3182-517a-85be-6acc656616c5","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"17d5ebf3-bdca-50d2-a4f5-245d191f4973","slug":"goals","fullItemName":"Goals"},{"id":"9162c6a3-edc4-5319-9418-04b2cb656ce6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2ae5c1d9-638e-52fa-b738-9561cd11b0ab","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7fec82ae-e144-56a7-b1e8-8744c35e227e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"610f052f-83a2-5b06-b5e6-4aa272ef73a6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a578bde3-0d84-54f7-814d-18ed38e6038a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"66bb9b4f-4de2-5da7-aba1-ec9bff4b2454","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"4b8f382f-673d-5804-8291-438e21e32790","slug":"definition","fullItemName":"Definition"},{"id":"ef0d96cd-207c-5814-93cf-c96870e2251d","slug":"causes","fullItemName":"Causes"},{"id":"09adb285-1d01-592a-9443-295b45c7d78b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9bfb88d8-8d33-53a3-8d0e-1b202457fb2e","slug":"complications","fullItemName":"Complications"},{"id":"5ff1ef9f-bb77-5feb-bd5a-12d7b43cca9d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"cfe582c4-479a-5d44-b893-ac46a1a80b29","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"6884c3db-6165-566b-a4ca-3e933de77714","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"42799fb8-7252-541e-9af1-27ebc28710b7","slug":"assessment","fullItemName":"Assessment"},{"id":"e850b740-b6cf-55a7-aed8-7372b7f13b05","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"d817ab4c-e7a3-582a-94fa-fcffd9c2d4f6","slug":"screening","fullItemName":"Screening"}]},{"id":"b377a2c4-68d7-573f-912f-123b99d0aba1","slug":"management","fullItemName":"Management","subChapters":[{"id":"daacd844-c78f-5626-a2ea-93077f98f729","slug":"overt-hypothyroidism-non-pregnant","fullItemName":"Scenario: Overt hypothyroidism (non-pregnant)"},{"id":"e358d249-a2f3-5a06-b301-2119af9ae164","slug":"subclinical-hypothyroidism-non-pregnant","fullItemName":"Scenario: Subclinical hypothyroidism (non-pregnant)"},{"id":"9e4d552e-5fb3-571b-b14a-fec340b943f0","slug":"preconception-or-pregnant","fullItemName":"Scenario: Preconception or pregnant"},{"id":"611f3939-9d39-5545-b225-f9b33fdb095e","slug":"postpartum","fullItemName":"Scenario: Postpartum"}]},{"id":"7b2d6d51-4029-5c06-8789-30e0056076fa","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"ee5ac1fb-6ba7-5e52-9861-d62637c03bf0","slug":"levothyroxine","fullItemName":"Levothyroxine"}]},{"id":"2aaf1754-ba79-5b47-b2a5-74fe8f6af4da","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"7669c894-3a85-55c7-b689-cb4b710a838a","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"840d7de5-8c31-5696-9de6-c80ce1bbfec7","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"299c20bf-2a22-5681-99ad-5f02f1395969","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"dd3df39b-4a5c-5416-af8d-dcdbf46bd255","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a88d4431-778a-5793-9557-9f806339a95b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1987302d-f600-55e0-a528-d3486c49048e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a49e5d2f-75e4-5219-a4d6-fd4a5595a776","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"f1d76bc1-c8dd-515b-a709-48c70c829658"}},"staticQueryHashes":["3666801979"]}